Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis

Nephritis, Lupus Clinical Trial

Official title:
Evaluation of Efficacy and Safety of Glucocorticosteroid Combined With Oral T2 (Chloroform/Methanol Extract of Tripterygium Wilfordii Hook F) in the Treatment of Patients With Lupus Nephritis.

Status Recruiting

Clinical Trial Summary

Evaluation the clinical efficacy and safety profile of glucocorticosteroid combined with oral T2 (chloroform/methanol extract of Tripterygium wilfordii Hook F) in the treatment of patients with lupus nephritis. Open-labeled, randomized, prospective multi-center clinical trial. Observation period of 24 weeks.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01646736
Study type	Interventional
Source	Peking Union Medical College Hospital
Contact	Hua Chen, MD
Phone	+861069158797
Email	chenhua@pumch.cn
Status	Recruiting
Phase	Phase 2/Phase 3
Start date	July 2012
Completion date	December 2013

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00268567` - Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone	Phase 2/Phase 3
	Completed	`NCT01328834` - Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis	Phase 3